Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study

Rosas, 2021, Tocilizumab in hospitalized patients with severe COVID-19 pneumonia, N Engl J Med, 384, 1503, 10.1056/NEJMoa2028700 Horby, 2021, Dexamethasone in hospitalized patients with COVID-19, N Engl J Med, 384, 693, 10.1056/NEJMoa2021436 Group, 2021, Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet, 397, 1637, 10.1016/S0140-6736(21)00676-0 Cavalli, 2020, Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study, Lancet Rheumatol, 2, e325, 10.1016/S2665-9913(20)30127-2 Feldmann, 2020, Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed, Lancet, 395, 1407, 10.1016/S0140-6736(20)30858-8 Patel, 2021, A randomized trial of otilimab in severe COVID-19 pneumonia (OSCAR), medRxiv Song, 2020, Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis, Cell Metab, 32, 188, 10.1016/j.cmet.2020.06.016 Barberis, 2020, Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2, Int J Mol Sci, 21, 10.3390/ijms21228623 Thomas, 2020, COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status, JCI Insight, 5, 10.1172/jci.insight.140327 Su, 2020, Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19, Cell, 183, 1479, 10.1016/j.cell.2020.10.037 Overmyer, 2021, Large-scale multi-omic analysis of COVID-19 severity, Cell Syst, 12, 23, 10.1016/j.cels.2020.10.003 Olson, 2019, Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile, BMJ Open, 9, 10.1136/bmjopen-2019-032707 Chua, 2020, COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis, Nat Biotechnol, 38, 970, 10.1038/s41587-020-0602-4 Wilk, 2020, A single-cell atlas of the peripheral immune response in patients with severe COVID-19, Nat Med, 26, 1070, 10.1038/s41591-020-0944-y Bost, 2020, Host-viral infection maps reveal signatures of severe COVID-19 patients, Cell, 181, 1475, 10.1016/j.cell.2020.05.006 Murch, 2020, Common determinants of severe COVID-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14, Med Hypotheses, 144, 10.1016/j.mehy.2020.110168 Vanderboom, 2021, Proteomic signature of host response to SARS-CoV-2 infection in the nasopharynx, Mol Cell Proteomics, 20, 10.1016/j.mcpro.2021.100134 Li, 2017, VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism, Nat Commun, 8 Sánchez-Cerrillo, 2020, COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes, J Clin Invest, 130, 6290, 10.1172/JCI140335 Chun, 2021, Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection, JCI Insight, 6, 10.1172/jci.insight.148476 Mayr, 2021, Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers, EMBO Mol Med, 13, 10.15252/emmm.202012871 Ackermann, 2020, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19, N Engl J Med, 383, 120, 10.1056/NEJMoa2015432 Lipcsey, 2021, The outcome of critically ill COVID-19 patients is linked to thromboinflammation dominated by the kallikrein/kinin system, Front Immunol, 12, 10.3389/fimmu.2021.627579 Chen, 2020, Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China, J Cell Mol Med, 24, 2484, 10.1111/jcmm.14937 Rolin, 2014, Oxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytes, Toxins (Basel), 6, 2840, 10.3390/toxins6092840 Wallner, 2018, Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages, PLoS One, 13, 10.1371/journal.pone.0205706 Numata, 2015, Phosphatidylinositol inhibits respiratory syncytial virus infection, J Lipid Res, 56, 578, 10.1194/jlr.M055723 Petrache, 2005, Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice, Nat Med, 11, 491, 10.1038/nm1238 Courrol, 2021, SARS-CoV-2, hemoglobin and protoporphyrin IX: interactions and perspectives, Photodiagn Photodyn Ther, 34, 10.1016/j.pdpdt.2021.102324 Su, 2021, Desaturation and heme elevation during COVID-19 infection: a potential prognostic factor of heme oxygenase-1, J Microbiol Immunol Infect, 54, 113, 10.1016/j.jmii.2020.10.001 Firpo, 2021, Targeting polyamines inhibits coronavirus infection by reducing cellular attachment and entry, ACS Infect Dis, 7, 1423, 10.1021/acsinfecdis.0c00491 Kölker, 2001, 3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis, J Neurosci Res, 66, 666, 10.1002/jnr.10012 Mayneris-Perxachs, 2021, Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon, Comput Struct Biotechnol J, 19, 6080, 10.1016/j.csbj.2021.11.007 Abdulrab, 2020, Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm, Med Hypotheses, 143, 10.1016/j.mehy.2020.109897 Liu, 2021, Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection, Int J Biochem Cell Biol, 131, 10.1016/j.biocel.2020.105906 Su, 2009, Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance, Hepatology, 50, 77, 10.1002/hep.22960